AU3512595A - Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds - Google Patents

Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds

Info

Publication number
AU3512595A
AU3512595A AU35125/95A AU3512595A AU3512595A AU 3512595 A AU3512595 A AU 3512595A AU 35125/95 A AU35125/95 A AU 35125/95A AU 3512595 A AU3512595 A AU 3512595A AU 3512595 A AU3512595 A AU 3512595A
Authority
AU
Australia
Prior art keywords
magaining
antimicrobials
sexually transmitted
transmitted diseases
squalamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35125/95A
Inventor
Gurrinder Bedi
Leonard Jacob
Taffy Williams
Michael Zasloff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Magainin Pharmaceuticals Inc
Original Assignee
Magainin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magainin Pharmaceuticals Inc filed Critical Magainin Pharmaceuticals Inc
Publication of AU3512595A publication Critical patent/AU3512595A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
AU35125/95A 1994-09-13 1995-09-13 Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds Abandoned AU3512595A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30547594A 1994-09-13 1994-09-13
US305475 1994-09-13
PCT/US1995/011675 WO1996008270A2 (en) 1994-09-13 1995-09-13 Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds

Publications (1)

Publication Number Publication Date
AU3512595A true AU3512595A (en) 1996-03-29

Family

ID=23180966

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35125/95A Abandoned AU3512595A (en) 1994-09-13 1995-09-13 Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds

Country Status (2)

Country Link
AU (1) AU3512595A (en)
WO (1) WO1996008270A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856535A (en) * 1994-08-18 1999-01-05 Magainin Pharmaceuticals, Inc. Aminosterol ester compounds
FR2744453B1 (en) * 1996-02-05 1998-07-10 Transgene Sa LIPOPOLYAMINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, NUCLEIC ACID TRANSFER VECTORS AND PREPARATION METHOD
US7410959B1 (en) 2000-07-13 2008-08-12 Genaera Corporation Therapeutic uses for aminosterol compounds
DE69727384T2 (en) * 1996-05-24 2004-11-04 IC-VEC Ltd. POLYCATONIC STERIN DERIVATIVES FOR TRANSFECTION
US6133233A (en) * 1997-02-18 2000-10-17 Kansas State University Research Foundation Peptide modulation of reperfusion injury
NL1008139C2 (en) * 1998-01-27 1999-07-28 Stichting Tech Wetenschapp Antimicrobial peptides.
US6767904B2 (en) 1998-03-06 2004-07-27 Bringham Young University Steroid derived antibiotics
NL1010692C2 (en) * 1998-12-01 2000-06-06 Stichting Tech Wetenschapp Antiviral peptides.
US20070190558A1 (en) 2006-02-01 2007-08-16 Savage Paul B Cationic Steroid Antimicrobial Compositions and Methods of Use
WO2008048340A2 (en) 2006-02-01 2008-04-24 Brigham Young University Cationic steroid antimicrobial compositions for treating poxvirus infections
CA2640584C (en) * 2006-02-01 2015-12-01 Brigham Young University Cationic steroid antimicrobial compositions and methods of use
JP2007314432A (en) * 2006-05-23 2007-12-06 Japan Science & Technology Agency New antimicrobial peptide and serum-free medium containing the antimicrobial peptide as active ingredient
US8729058B2 (en) 2009-10-27 2014-05-20 Michael Zasloff Methods and compositions for treating and preventing viral infections
US8623416B2 (en) 2009-11-25 2014-01-07 Michael Zasloff Formulations comprising aminosterols
US10040817B2 (en) 2013-10-03 2018-08-07 Enterin Laboratories, Inc. Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same
MA50094A (en) 2017-09-08 2020-07-15 Enterin Inc METHODS OF TREATING SLEEP DISORDERS, SLEEP DISTURBANCES AND RELATED SYMPTOMS USING AMINOSTEROL COMPOSITIONS
US20210186989A1 (en) * 2018-06-06 2021-06-24 Centro Nacional De Investigaciones Cardiovasculares Carlos Iii Enhanced trained immunity in myeloid cells by ship-1 inhibition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8104929A (en) * 1980-11-12 1982-06-01 Alza Corp ANTICHOLINERGIC PREPARATIONS, PREPARATION AND USE THEREOF.
DE3850107T2 (en) * 1987-03-04 1995-02-23 Us Health NEW SYNTHETIC BIOACTIVE COMPOUNDS AND METHOD FOR PRODUCING BIOACTIVE EFFECTS.
US4832953A (en) * 1987-08-13 1989-05-23 Alza Corporation Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
EP0356382B1 (en) * 1988-08-02 1994-02-16 Ciba-Geigy Ag Multilayer plaster
DE3908431A1 (en) * 1989-03-15 1990-09-27 Lohmann Therapie Syst Lts TRANSDERMAL SYSTEM WITH STAGE SUBSTANCE DELIVERY AND USE FOR LOCAL OR SYSTEMIC DISPENSER
JPH04261119A (en) * 1991-02-13 1992-09-17 Lintec Corp Percutaneous absorption-type pharmaceutical preparation
AU665030B2 (en) * 1991-09-13 1995-12-14 Magainin Pharmaceuticals, Inc. Biologically active amphiphilic peptide compositions and uses therefor
WO1993024138A1 (en) * 1992-06-01 1993-12-09 Magainin Pharmaceuticals, Inc. Biologically active peptides having n-terminal substitutions
AU5081193A (en) * 1992-08-31 1994-03-29 Magainin Pharmaceuticals, Inc. Treatment of gynecological malignancies with biologically active peptides

Also Published As

Publication number Publication date
WO1996008270A3 (en) 1996-05-17
WO1996008270A2 (en) 1996-03-21

Similar Documents

Publication Publication Date Title
EP1382399B8 (en) Method for repelling or eliminating harmful organism
AU5855796A (en) Methods for inhibiting bone loss
AU689693B2 (en) Control apparatus for multi-air-conditioner
AU3512595A (en) Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds
AU1128297A (en) Composition for treating pain
AU1139095A (en) Combination treatment for osteoporosis
AU4017395A (en) Method for treating anxiety
EP0678344A3 (en) Method for forming water-repellant film
AU1074397A (en) Method for treating anxiety
AU4362896A (en) Method for transferring waste
AU679312B2 (en) Apparatus for electro-fishing
EP0727598A3 (en) Control apparatus for transmission
AU5743396A (en) Methods for inhibiting bone loss
AU3126495A (en) Process for making alkyl polyglycosides
AU7726396A (en) Method for treating anxiety
AU2008595A (en) Method of printing
AU7674796A (en) Method for treating anxiety
AU1597095A (en) Method for making alkyl polyglycosides
AU5743696A (en) Methods for inhibiting bone loss
AU2611695A (en) Sailboatsystem for controlled gibing
AU1532599A (en) Method for publishing quick-reference bibles
AU4017195A (en) Method for treating anxiety
AU1728995A (en) Inhibition of vacuolar h+ -atpase by phosphorothioate oligonucleotides
AU1521495A (en) Method for synthesizing 5-aminotetrazole
AP9701121A0 (en) Method for prearing streptogramines